Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine vs sufentanil for postoperative patient-controlled intravenous analgesia after thoracoscopic–laparoscopic three-incision esophagectomy in elderly patients
ChiCTR2300068230Phase 4Not yet recruiting
- Sponsor
- Shandong Cancer Hospital
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in esophageal cancer (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoints: Pain score, Immunologic function and 1 more. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR2300068230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068230.